
    
      To investigate the potential for drug interactions between simeprevir and dolutegravir,
      participants will receive each drug alone and the drugs in combination for 7 days. The
      pharmacokinetics of simeprevir and dolutegravir when given in combination vs. alone will be
      compared.
    
  